Previous Close | 47.93 |
Open | 47.86 |
Bid | 46.27 x 200 |
Ask | 46.34 x 200 |
Day's Range | 46.29 - 47.99 |
52 Week Range | 43.42 - 91.10 |
Volume | |
Avg. Volume | 1,108,862 |
Market Cap | 3.951B |
Beta (5Y Monthly) | 1.67 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.20 |
Earnings Date | Nov 04, 2024 - Nov 08, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 80.92 |
We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other most promising gene editing stocks to buy according to hedge funds. The pharmaceutical industry remains a hub of […]
On CRSP's third-quarter 2024 earnings call, investors will likely focus on the sales numbers of its recently approved gene therapy, Casgevy.